Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-operative observational strategy for small non-functioning pancreatic neuroendocrine neoplasms: A feasible option?

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2025
Same author

Clinically Adult-Onset Nesidioblastosis with Repeated Severe Hypoglycemia, Successfully Treated by Two Times Pancreatectomies. A Rare Case Report.

Clinical and experimental gastroenterology·2025
Same author

Clinicopathological Relevance of SMAD4 and RUNX3 in Patients With Resected Pancreatic Cancer.

Pancreas·2025
Same author

The importance of microvascular invasion in patients with non-functioning pancreatic neuroendocrine neoplasm.

Langenbeck's archives of surgery·2024
Same author

Comprehensive data of 5085 patients newly diagnosed with colorectal liver metastasis between 2013 and 2017: Fourth report of a nationwide survey in Japan.

Journal of hepato-biliary-pancreatic sciences·2024
Same author

Evaluation of two-stage hepatectomy using portal vein embolization for colorectal liver metastasis: a retrospective nationwide cohort survey in Japan.

International journal of surgery (London, England)·2024

Related Experiment Video

Updated: Mar 8, 2026

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

902

Intrahepatic cholangiocarcinoma.

Masayuki Nakano1, Shun-Ichi Ariizumi2, Masakazu Yamamoto2

  • 1Division of Diagnostic Pathology, Shonan Fujisawa Tokushuukai Hospita, Japan.

Seminars in Diagnostic Pathology
|January 18, 2017
PubMed
Summary

Cholangiocarcinoma, a bile duct cancer, presents in intrahepatic, perihilar, and distal forms. Intrahepatic cholangiocarcinoma has subtypes with varying prognoses, with cholangiolar tumors showing better survival rates.

Keywords:
Cholangiolocellular carcinomaInfiltrating cholangiocarcinomaMass forming cholangiocarcinomaPeriductal cholangiocarcinomaVictoria blue stain

More Related Videos

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

59
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

887

Related Experiment Videos

Last Updated: Mar 8, 2026

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

902
Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

59
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

887

Area of Science:

  • Hepatobiliary cancers
  • Gastroenterology
  • Oncology

Background:

  • Cholangiocarcinoma (bile duct cancer) originates in the biliary tract.
  • Tumors can be intrahepatic or extrahepatic, with distinct features and treatments.
  • Classification systems by EASL and Mayo Clinic categorize tumors into intrahepatic, perihilar, and distal types.

Observation:

  • Macroscopic growth patterns include mass-forming, periductal-infiltrating, and intraductal.
  • Combined mass-forming and periductal-infiltrating patterns are associated with poor prognosis.
  • Intrahepatic cholangiocarcinoma (ICC) has two microscopic subtypes: bile duct and cholangiolar.

Findings:

  • The bile duct subtype of ICC features tall columnar cells forming large glands.
  • Cholangiolar tumors consist of cuboidal and low columnar cells.
  • Cholangiolar tumors, also termed cholangiolocellular carcinoma, demonstrate a better 5-year survival rate compared to the bile duct type.

Implications:

  • Understanding ICC subtypes is crucial for accurate prognostication.
  • Microscopic differentiation may guide treatment strategies for intrahepatic cholangiocarcinoma.
  • Further research into cholangiolar carcinoma could reveal novel therapeutic targets.